DNA X, Inc. (NASDAQ: SONM) Stock Competitors & Peer Comparison

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, CSCO has a market cap of 457.2B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while CSCO trades at $115.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas CSCO's P/E ratio is 28.36. In terms of profitability, SONM's ROE is +6.68%, compared to CSCO's ROE of +0.25%. Regarding short-term risk, SONM is more volatile compared to CSCO. This indicates higher risk in terms of short-term price fluctuations for SONM.Check CSCO's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, MSI has a market cap of 72.4B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while MSI trades at $435.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas MSI's P/E ratio is 27.96. In terms of profitability, SONM's ROE is +6.68%, compared to MSI's ROE of +0.90%. Regarding short-term risk, SONM is more volatile compared to MSI. This indicates higher risk in terms of short-term price fluctuations for SONM.Check MSI's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, LITE has a market cap of 55.5B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while LITE trades at $713.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas LITE's P/E ratio is 118.59. In terms of profitability, SONM's ROE is +6.68%, compared to LITE's ROE of +0.31%. Regarding short-term risk, SONM is less volatile compared to LITE. This indicates lower risk in terms of short-term price fluctuations for SONM.Check LITE's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, CIEN has a market cap of 53.3B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while CIEN trades at $377.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas CIEN's P/E ratio is 82.46. In terms of profitability, SONM's ROE is +6.68%, compared to CIEN's ROE of +0.16%. Regarding short-term risk, SONM is more volatile compared to CIEN. This indicates higher risk in terms of short-term price fluctuations for SONM.Check CIEN's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, NOK has a market cap of 49.1B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while NOK trades at $9.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas NOK's P/E ratio is 23.33. In terms of profitability, SONM's ROE is +6.68%, compared to NOK's ROE of +0.03%. Regarding short-term risk, SONM is more volatile compared to NOK. This indicates higher risk in terms of short-term price fluctuations for SONM.Check NOK's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, UI has a market cap of 33.7B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while UI trades at $556.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas UI's P/E ratio is 37.74. In terms of profitability, SONM's ROE is +6.68%, compared to UI's ROE of +1.01%. Regarding short-term risk, SONM is more volatile compared to UI. This indicates higher risk in terms of short-term price fluctuations for SONM.Check UI's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, ERIC has a market cap of 32.2B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while ERIC trades at $9.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas ERIC's P/E ratio is 16.64. In terms of profitability, SONM's ROE is +6.68%, compared to ERIC's ROE of +0.23%. Regarding short-term risk, SONM is more volatile compared to ERIC. This indicates higher risk in terms of short-term price fluctuations for SONM.Check ERIC's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, ZBRA has a market cap of 14B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while ZBRA trades at $293.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas ZBRA's P/E ratio is 17.73. In terms of profitability, SONM's ROE is +6.68%, compared to ZBRA's ROE of +0.12%. Regarding short-term risk, SONM is more volatile compared to ZBRA. This indicates higher risk in terms of short-term price fluctuations for SONM.Check ZBRA's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, JNPR has a market cap of 13.4B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while JNPR trades at $39.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas JNPR's P/E ratio is 38.05. In terms of profitability, SONM's ROE is +6.68%, compared to JNPR's ROE of +0.06%. Regarding short-term risk, SONM is more volatile compared to JNPR. This indicates higher risk in terms of short-term price fluctuations for SONM.Check JNPR's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, VSAT has a market cap of 10.6B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while VSAT trades at $76.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas VSAT's P/E ratio is 427.39. In terms of profitability, SONM's ROE is +6.68%, compared to VSAT's ROE of -0.01%. Regarding short-term risk, SONM is more volatile compared to VSAT. This indicates higher risk in terms of short-term price fluctuations for SONM.Check VSAT's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, VIAV has a market cap of 9.1B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while VIAV trades at $36.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas VIAV's P/E ratio is 47.96. In terms of profitability, SONM's ROE is +6.68%, compared to VIAV's ROE of -0.07%. Regarding short-term risk, SONM is more volatile compared to VIAV. This indicates higher risk in terms of short-term price fluctuations for SONM.Check VIAV's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, AAOI has a market cap of 7.6B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while AAOI trades at $94.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas AAOI's P/E ratio is -285.82. In terms of profitability, SONM's ROE is +6.68%, compared to AAOI's ROE of -0.06%. Regarding short-term risk, SONM is less volatile compared to AAOI. This indicates lower risk in terms of short-term price fluctuations for SONM.Check AAOI's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, REZI has a market cap of 5.2B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while REZI trades at $34.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas REZI's P/E ratio is 12.70. In terms of profitability, SONM's ROE is +6.68%, compared to REZI's ROE of -0.18%. Regarding short-term risk, SONM is more volatile compared to REZI. This indicates higher risk in terms of short-term price fluctuations for SONM.Check REZI's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, BDC has a market cap of 4.8B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while BDC trades at $124.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas BDC's P/E ratio is 16.09. In terms of profitability, SONM's ROE is +6.68%, compared to BDC's ROE of +0.19%. Regarding short-term risk, SONM is more volatile compared to BDC. This indicates higher risk in terms of short-term price fluctuations for SONM.Check BDC's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, ONDS has a market cap of 4.3B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while ONDS trades at $7.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas ONDS's P/E ratio is -11.52. In terms of profitability, SONM's ROE is +6.68%, compared to ONDS's ROE of +0.47%. Regarding short-term risk, SONM is less volatile compared to ONDS. This indicates lower risk in terms of short-term price fluctuations for SONM.Check ONDS's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, MAXR has a market cap of 4B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while MAXR trades at $52.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas MAXR's P/E ratio is -26.10. In terms of profitability, SONM's ROE is +6.68%, compared to MAXR's ROE of -0.11%. Regarding short-term risk, SONM is more volatile compared to MAXR. This indicates higher risk in terms of short-term price fluctuations for SONM.Check MAXR's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, COMM has a market cap of 3.9B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while COMM trades at $17.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas COMM's P/E ratio is 15.23. In terms of profitability, SONM's ROE is +6.68%, compared to COMM's ROE of +10.68%. Regarding short-term risk, SONM is more volatile compared to COMM. This indicates higher risk in terms of short-term price fluctuations for SONM.Check COMM's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, EXTR has a market cap of 3.9B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while EXTR trades at $30.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas EXTR's P/E ratio is 30.44. In terms of profitability, SONM's ROE is +6.68%, compared to EXTR's ROE of +0.21%. Regarding short-term risk, SONM is more volatile compared to EXTR. This indicates higher risk in terms of short-term price fluctuations for SONM.Check EXTR's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, VISN has a market cap of 2.6B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while VISN trades at $11.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas VISN's P/E ratio is 11.25. In terms of profitability, SONM's ROE is +6.68%, compared to VISN's ROE of +0.00%. Regarding short-term risk, SONM is more volatile compared to VISN. This indicates higher risk in terms of short-term price fluctuations for SONM.Check VISN's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, DGII has a market cap of 2.6B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while DGII trades at $69.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas DGII's P/E ratio is 30.71. In terms of profitability, SONM's ROE is +6.68%, compared to DGII's ROE of +0.07%. Regarding short-term risk, SONM is more volatile compared to DGII. This indicates higher risk in terms of short-term price fluctuations for SONM.Check DGII's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, CALX has a market cap of 2.3B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while CALX trades at $35.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas CALX's P/E ratio is 23.01. In terms of profitability, SONM's ROE is +6.68%, compared to CALX's ROE of +0.07%. Regarding short-term risk, SONM is more volatile compared to CALX. This indicates higher risk in terms of short-term price fluctuations for SONM.Check CALX's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, INFN has a market cap of 1.6B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while INFN trades at $6.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas INFN's P/E ratio is -10.38. In terms of profitability, SONM's ROE is +6.68%, compared to INFN's ROE of -0.90%. Regarding short-term risk, SONM is more volatile compared to INFN. This indicates higher risk in terms of short-term price fluctuations for SONM.Check INFN's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, ARLO has a market cap of 1.6B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while ARLO trades at $14.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas ARLO's P/E ratio is 17.44. In terms of profitability, SONM's ROE is +6.68%, compared to ARLO's ROE of +0.23%. Regarding short-term risk, SONM is more volatile compared to ARLO. This indicates higher risk in terms of short-term price fluctuations for SONM.Check ARLO's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, HLIT has a market cap of 1.3B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while HLIT trades at $11.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas HLIT's P/E ratio is 22.21. In terms of profitability, SONM's ROE is +6.68%, compared to HLIT's ROE of -0.10%. Regarding short-term risk, SONM is more volatile compared to HLIT. This indicates higher risk in terms of short-term price fluctuations for SONM.Check HLIT's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, SWIR has a market cap of 1.2B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while SWIR trades at $30.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas SWIR's P/E ratio is -22.82. In terms of profitability, SONM's ROE is +6.68%, compared to SWIR's ROE of N/A. Regarding short-term risk, SONM is more volatile compared to SWIR. This indicates higher risk in terms of short-term price fluctuations for SONM.Check SWIR's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, ITRN has a market cap of 1.1B. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while ITRN trades at $55.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas ITRN's P/E ratio is 18.20. In terms of profitability, SONM's ROE is +6.68%, compared to ITRN's ROE of +0.29%. Regarding short-term risk, SONM is more volatile compared to ITRN. This indicates higher risk in terms of short-term price fluctuations for SONM.Check ITRN's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, GILT has a market cap of 834M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while GILT trades at $11.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas GILT's P/E ratio is 14.17. In terms of profitability, SONM's ROE is +6.68%, compared to GILT's ROE of +0.07%. Regarding short-term risk, SONM is more volatile compared to GILT. This indicates higher risk in terms of short-term price fluctuations for SONM.Check GILT's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, POLY has a market cap of 790.5M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while POLY trades at $39.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas POLY's P/E ratio is 75.13. In terms of profitability, SONM's ROE is +6.68%, compared to POLY's ROE of -0.59%. Regarding short-term risk, SONM is more volatile compared to POLY. This indicates higher risk in terms of short-term price fluctuations for SONM.Check POLY's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, ADTN has a market cap of 689.3M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while ADTN trades at $8.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas ADTN's P/E ratio is 26.59. In terms of profitability, SONM's ROE is +6.68%, compared to ADTN's ROE of -0.24%. Regarding short-term risk, SONM is more volatile compared to ADTN. This indicates higher risk in terms of short-term price fluctuations for SONM.Check ADTN's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, NTGR has a market cap of 648.5M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while NTGR trades at $24.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas NTGR's P/E ratio is 48.32. In terms of profitability, SONM's ROE is +6.68%, compared to NTGR's ROE of -0.08%. Regarding short-term risk, SONM is more volatile compared to NTGR. This indicates higher risk in terms of short-term price fluctuations for SONM.Check NTGR's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, FEIM has a market cap of 572.2M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while FEIM trades at $57.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas FEIM's P/E ratio is 77.29. In terms of profitability, SONM's ROE is +6.68%, compared to FEIM's ROE of -0.02%. Regarding short-term risk, SONM is more volatile compared to FEIM. This indicates higher risk in terms of short-term price fluctuations for SONM.Check FEIM's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, PWFL has a market cap of 490.6M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while PWFL trades at $4.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas PWFL's P/E ratio is -9.33. In terms of profitability, SONM's ROE is +6.68%, compared to PWFL's ROE of -0.03%. Regarding short-term risk, SONM is more volatile compared to PWFL. This indicates higher risk in terms of short-term price fluctuations for SONM.Check PWFL's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, CLFD has a market cap of 411.2M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while CLFD trades at $30.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas CLFD's P/E ratio is 168.11. In terms of profitability, SONM's ROE is +6.68%, compared to CLFD's ROE of -0.03%. Regarding short-term risk, SONM is more volatile compared to CLFD. This indicates higher risk in terms of short-term price fluctuations for SONM.Check CLFD's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, ITI has a market cap of 309.5M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while ITI trades at $7.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas ITI's P/E ratio is 239.67. In terms of profitability, SONM's ROE is +6.68%, compared to ITI's ROE of +0.05%. Regarding short-term risk, SONM is more volatile compared to ITI. This indicates higher risk in terms of short-term price fluctuations for SONM.Check ITI's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, BKTI has a market cap of 299.7M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while BKTI trades at $80.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas BKTI's P/E ratio is 17.33. In terms of profitability, SONM's ROE is +6.68%, compared to BKTI's ROE of +0.33%. Regarding short-term risk, SONM is more volatile compared to BKTI. This indicates higher risk in terms of short-term price fluctuations for SONM.Check BKTI's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, AVNW has a market cap of 265M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while AVNW trades at $20.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas AVNW's P/E ratio is 11.01. In terms of profitability, SONM's ROE is +6.68%, compared to AVNW's ROE of +0.03%. Regarding short-term risk, SONM is more volatile compared to AVNW. This indicates higher risk in terms of short-term price fluctuations for SONM.Check AVNW's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, SATX has a market cap of 256.5M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while SATX trades at $2.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas SATX's P/E ratio is -5.69. In terms of profitability, SONM's ROE is +6.68%, compared to SATX's ROE of +0.57%. Regarding short-term risk, SONM is more volatile compared to SATX. This indicates higher risk in terms of short-term price fluctuations for SONM.Check SATX's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, AUDC has a market cap of 243.8M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while AUDC trades at $9.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas AUDC's P/E ratio is 15.70. In terms of profitability, SONM's ROE is +6.68%, compared to AUDC's ROE of +0.04%. Regarding short-term risk, SONM is more volatile compared to AUDC. This indicates higher risk in terms of short-term price fluctuations for SONM.Check AUDC's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, LTRX has a market cap of 240M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while LTRX trades at $5.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas LTRX's P/E ratio is 41.38. In terms of profitability, SONM's ROE is +6.68%, compared to LTRX's ROE of -0.09%. Regarding short-term risk, SONM is more volatile compared to LTRX. This indicates higher risk in terms of short-term price fluctuations for SONM.Check LTRX's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, SILC has a market cap of 228.9M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while SILC trades at $39.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas SILC's P/E ratio is -30.64. In terms of profitability, SONM's ROE is +6.68%, compared to SILC's ROE of -0.08%. Regarding short-term risk, SONM is more volatile compared to SILC. This indicates higher risk in terms of short-term price fluctuations for SONM.Check SILC's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, CRNT has a market cap of 197.2M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while CRNT trades at $2.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas CRNT's P/E ratio is 27.13. In terms of profitability, SONM's ROE is +6.68%, compared to CRNT's ROE of -0.01%. Regarding short-term risk, SONM is more volatile compared to CRNT. This indicates higher risk in terms of short-term price fluctuations for SONM.Check CRNT's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, KVHI has a market cap of 180.5M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while KVHI trades at $9.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas KVHI's P/E ratio is -35.62. In terms of profitability, SONM's ROE is +6.68%, compared to KVHI's ROE of -0.04%. Regarding short-term risk, SONM is more volatile compared to KVHI. This indicates higher risk in terms of short-term price fluctuations for SONM.Check KVHI's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, PCTI has a market cap of 135.3M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while PCTI trades at $6.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas PCTI's P/E ratio is 30.39. In terms of profitability, SONM's ROE is +6.68%, compared to PCTI's ROE of +0.04%. Regarding short-term risk, SONM is more volatile compared to PCTI. This indicates higher risk in terms of short-term price fluctuations for SONM.Check PCTI's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, OCC has a market cap of 131.2M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while OCC trades at $14.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas OCC's P/E ratio is 123.83. In terms of profitability, SONM's ROE is +6.68%, compared to OCC's ROE of +0.05%. Regarding short-term risk, SONM is less volatile compared to OCC. This indicates lower risk in terms of short-term price fluctuations for SONM.Check OCC's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, AMPG has a market cap of 117.8M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while AMPG trades at $4.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas AMPG's P/E ratio is -15.00. In terms of profitability, SONM's ROE is +6.68%, compared to AMPG's ROE of -0.18%. Regarding short-term risk, SONM is less volatile compared to AMPG. This indicates lower risk in terms of short-term price fluctuations for SONM.Check AMPG's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, INSG has a market cap of 114.4M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while INSG trades at $7.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas INSG's P/E ratio is 29.29. In terms of profitability, SONM's ROE is +6.68%, compared to INSG's ROE of +0.18%. Regarding short-term risk, SONM is more volatile compared to INSG. This indicates higher risk in terms of short-term price fluctuations for SONM.Check INSG's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, TESS has a market cap of 83.3M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while TESS trades at $8.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas TESS's P/E ratio is -19.13. In terms of profitability, SONM's ROE is +6.68%, compared to TESS's ROE of -0.06%. Regarding short-term risk, SONM is more volatile compared to TESS. This indicates higher risk in terms of short-term price fluctuations for SONM.Check TESS's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, JCS has a market cap of 77M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while JCS trades at $8.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas JCS's P/E ratio is 6.60. In terms of profitability, SONM's ROE is +6.68%, compared to JCS's ROE of -0.38%. Regarding short-term risk, SONM is less volatile compared to JCS. This indicates lower risk in terms of short-term price fluctuations for SONM.Check JCS's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, GNSS has a market cap of 76.1M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while GNSS trades at $1.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas GNSS's P/E ratio is -9.82. In terms of profitability, SONM's ROE is +6.68%, compared to GNSS's ROE of -3.15%. Regarding short-term risk, SONM is more volatile compared to GNSS. This indicates higher risk in terms of short-term price fluctuations for SONM.Check GNSS's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, AIRG has a market cap of 72.8M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while AIRG trades at $5.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas AIRG's P/E ratio is -41.00. In terms of profitability, SONM's ROE is +6.68%, compared to AIRG's ROE of -0.23%. Regarding short-term risk, SONM is more volatile compared to AIRG. This indicates higher risk in terms of short-term price fluctuations for SONM.Check AIRG's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, CMTL has a market cap of 50.3M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while CMTL trades at $1.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas CMTL's P/E ratio is -1.04. In terms of profitability, SONM's ROE is +6.68%, compared to CMTL's ROE of -0.09%. Regarding short-term risk, SONM is more volatile compared to CMTL. This indicates higher risk in terms of short-term price fluctuations for SONM.Check CMTL's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, MOBBW has a market cap of 47.8M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while MOBBW trades at $1.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas MOBBW's P/E ratio is -0.44. In terms of profitability, SONM's ROE is +6.68%, compared to MOBBW's ROE of -3.49%. Regarding short-term risk, SONM is less volatile compared to MOBBW. This indicates lower risk in terms of short-term price fluctuations for SONM.Check MOBBW's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, WTT has a market cap of 45.3M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while WTT trades at $2.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas WTT's P/E ratio is -19.32. In terms of profitability, SONM's ROE is +6.68%, compared to WTT's ROE of -0.07%. Regarding short-term risk, SONM is more volatile compared to WTT. This indicates higher risk in terms of short-term price fluctuations for SONM.Check WTT's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, SYTA has a market cap of 38M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while SYTA trades at $3.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas SYTA's P/E ratio is 0.00. In terms of profitability, SONM's ROE is +6.68%, compared to SYTA's ROE of -0.66%. Regarding short-term risk, SONM is less volatile compared to SYTA. This indicates lower risk in terms of short-term price fluctuations for SONM.Check SYTA's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, BOSC has a market cap of 31.7M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while BOSC trades at $4.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas BOSC's P/E ratio is 7.89. In terms of profitability, SONM's ROE is +6.68%, compared to BOSC's ROE of +0.11%. Regarding short-term risk, SONM is more volatile compared to BOSC. This indicates higher risk in terms of short-term price fluctuations for SONM.Check BOSC's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, FKWL has a market cap of 26.9M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while FKWL trades at $2.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas FKWL's P/E ratio is -25.33. In terms of profitability, SONM's ROE is +6.68%, compared to FKWL's ROE of -0.02%. Regarding short-term risk, SONM is more volatile compared to FKWL. This indicates higher risk in terms of short-term price fluctuations for SONM.Check FKWL's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, UTSI has a market cap of 22.6M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while UTSI trades at $2.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas UTSI's P/E ratio is -3.40. In terms of profitability, SONM's ROE is +6.68%, compared to UTSI's ROE of -0.20%. Regarding short-term risk, SONM is more volatile compared to UTSI. This indicates higher risk in terms of short-term price fluctuations for SONM.Check UTSI's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, MINM has a market cap of 13.4M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while MINM trades at $3.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas MINM's P/E ratio is -13.88. In terms of profitability, SONM's ROE is +6.68%, compared to MINM's ROE of +0.23%. Regarding short-term risk, SONM is less volatile compared to MINM. This indicates lower risk in terms of short-term price fluctuations for SONM.Check MINM's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, FIEE has a market cap of 11.1M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while FIEE trades at $2.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas FIEE's P/E ratio is 42.71. In terms of profitability, SONM's ROE is +6.68%, compared to FIEE's ROE of +0.32%. Regarding short-term risk, SONM is less volatile compared to FIEE. This indicates lower risk in terms of short-term price fluctuations for SONM.Check FIEE's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, MTEK has a market cap of 10.6M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while MTEK trades at $1.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas MTEK's P/E ratio is -2.95. In terms of profitability, SONM's ROE is +6.68%, compared to MTEK's ROE of -2.63%. Regarding short-term risk, SONM is more volatile compared to MTEK. This indicates higher risk in terms of short-term price fluctuations for SONM.Check MTEK's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, IOTR has a market cap of 8.6M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while IOTR trades at $2.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas IOTR's P/E ratio is -14.20. In terms of profitability, SONM's ROE is +6.68%, compared to IOTR's ROE of -0.24%. Regarding short-term risk, SONM is less volatile compared to IOTR. This indicates lower risk in terms of short-term price fluctuations for SONM.Check IOTR's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, CLRO has a market cap of 7.1M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while CLRO trades at $4.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas CLRO's P/E ratio is -0.61. In terms of profitability, SONM's ROE is +6.68%, compared to CLRO's ROE of -5.21%. Regarding short-term risk, SONM is less volatile compared to CLRO. This indicates lower risk in terms of short-term price fluctuations for SONM.Check CLRO's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, SYNX has a market cap of 6.6M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while SYNX trades at $1.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas SYNX's P/E ratio is -4.17. In terms of profitability, SONM's ROE is +6.68%, compared to SYNX's ROE of -0.51%. Regarding short-term risk, SONM is more volatile compared to SYNX. This indicates higher risk in terms of short-term price fluctuations for SONM.Check SYNX's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, MITQ has a market cap of 5.3M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while MITQ trades at $0.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas MITQ's P/E ratio is -26.57. In terms of profitability, SONM's ROE is +6.68%, compared to MITQ's ROE of -0.03%. Regarding short-term risk, SONM is more volatile compared to MITQ. This indicates higher risk in terms of short-term price fluctuations for SONM.Check MITQ's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, CMBM has a market cap of 3.7M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while CMBM trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas CMBM's P/E ratio is -0.04. In terms of profitability, SONM's ROE is +6.68%, compared to CMBM's ROE of +0.97%. Regarding short-term risk, SONM is less volatile compared to CMBM. This indicates lower risk in terms of short-term price fluctuations for SONM.Check CMBM's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, CASA has a market cap of 3.5M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while CASA trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas CASA's P/E ratio is -0.03. In terms of profitability, SONM's ROE is +6.68%, compared to CASA's ROE of -1.21%. Regarding short-term risk, SONM is less volatile compared to CASA. This indicates lower risk in terms of short-term price fluctuations for SONM.Check CASA's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, FXHO has a market cap of 2.1M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while FXHO trades at $10.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas FXHO's P/E ratio is N/A. In terms of profitability, SONM's ROE is +6.68%, compared to FXHO's ROE of N/A. Regarding short-term risk, SONM is less volatile compared to FXHO. This indicates lower risk in terms of short-term price fluctuations for SONM.Check FXHO's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, MYNA has a market cap of 1.7M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while MYNA trades at $0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas MYNA's P/E ratio is -0.06. In terms of profitability, SONM's ROE is +6.68%, compared to MYNA's ROE of +8.70%. Regarding short-term risk, SONM is less volatile compared to MYNA. This indicates lower risk in terms of short-term price fluctuations for SONM.Check MYNA's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, AMPGW has a market cap of 1.6M. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while AMPGW trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas AMPGW's P/E ratio is -0.26. In terms of profitability, SONM's ROE is +6.68%, compared to AMPGW's ROE of -0.18%. Regarding short-term risk, SONM is less volatile compared to AMPGW. This indicates lower risk in terms of short-term price fluctuations for SONM.Check AMPGW's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, ASNS has a market cap of 983.1K. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while ASNS trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas ASNS's P/E ratio is -0.02. In terms of profitability, SONM's ROE is +6.68%, compared to ASNS's ROE of -2.04%. Regarding short-term risk, SONM is less volatile compared to ASNS. This indicates lower risk in terms of short-term price fluctuations for SONM.Check ASNS's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, EVLVW has a market cap of 724.4K. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while EVLVW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas EVLVW's P/E ratio is -0.01. In terms of profitability, SONM's ROE is +6.68%, compared to EVLVW's ROE of -0.34%. Regarding short-term risk, SONM is more volatile compared to EVLVW. This indicates higher risk in terms of short-term price fluctuations for SONM.Check EVLVW's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, SYTAW has a market cap of 55.8K. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while SYTAW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas SYTAW's P/E ratio is N/A. In terms of profitability, SONM's ROE is +6.68%, compared to SYTAW's ROE of -3.61%. Regarding short-term risk, SONM is less volatile compared to SYTAW. This indicates lower risk in terms of short-term price fluctuations for SONM.Check SYTAW's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, BRCD has a market cap of 0. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while BRCD trades at $12.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas BRCD's P/E ratio is N/A. In terms of profitability, SONM's ROE is +6.68%, compared to BRCD's ROE of +0.08%. Regarding short-term risk, SONM is more volatile compared to BRCD. This indicates higher risk in terms of short-term price fluctuations for SONM.Check BRCD's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, RKUS has a market cap of 0. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while RKUS trades at $12.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas RKUS's P/E ratio is 256.37. In terms of profitability, SONM's ROE is +6.68%, compared to RKUS's ROE of +0.02%. Regarding short-term risk, SONM is more volatile compared to RKUS. This indicates higher risk in terms of short-term price fluctuations for SONM.Check RKUS's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, CALL has a market cap of 0. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while CALL trades at $10.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas CALL's P/E ratio is 26.89. In terms of profitability, SONM's ROE is +6.68%, compared to CALL's ROE of -0.53%. Regarding short-term risk, SONM is more volatile compared to CALL. This indicates higher risk in terms of short-term price fluctuations for SONM.Check CALL's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, ZXZZT has a market cap of 0. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while ZXZZT trades at $25.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas ZXZZT's P/E ratio is N/A. In terms of profitability, SONM's ROE is +6.68%, compared to ZXZZT's ROE of N/A. Regarding short-term risk, SONM is more volatile compared to ZXZZT. This indicates higher risk in terms of short-term price fluctuations for SONM.Check ZXZZT's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, MITL has a market cap of 0. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while MITL trades at $11.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas MITL's P/E ratio is -96.60. In terms of profitability, SONM's ROE is +6.68%, compared to MITL's ROE of -0.13%. Regarding short-term risk, SONM is more volatile compared to MITL. This indicates higher risk in terms of short-term price fluctuations for SONM.Check MITL's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, ORBC has a market cap of 0. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while ORBC trades at $11.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas ORBC's P/E ratio is N/A. In terms of profitability, SONM's ROE is +6.68%, compared to ORBC's ROE of -0.15%. Regarding short-term risk, SONM is more volatile compared to ORBC. This indicates higher risk in terms of short-term price fluctuations for SONM.Check ORBC's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, SSNI has a market cap of 0. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while SSNI trades at $16.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas SSNI's P/E ratio is -21.97. In terms of profitability, SONM's ROE is +6.68%, compared to SSNI's ROE of +0.66%. Regarding short-term risk, SONM is more volatile compared to SSNI. This indicates higher risk in terms of short-term price fluctuations for SONM.Check SSNI's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, VCRA has a market cap of 0. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while VCRA trades at $79.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas VCRA's P/E ratio is -316.52. In terms of profitability, SONM's ROE is +6.68%, compared to VCRA's ROE of -0.05%. Regarding short-term risk, SONM is more volatile compared to VCRA. This indicates higher risk in terms of short-term price fluctuations for SONM.Check VCRA's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, SATX-WTA has a market cap of 0. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while SATX-WTA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas SATX-WTA's P/E ratio is N/A. In terms of profitability, SONM's ROE is +6.68%, compared to SATX-WTA's ROE of +0.57%. Regarding short-term risk, SONM is less volatile compared to SATX-WTA. This indicates lower risk in terms of short-term price fluctuations for SONM.Check SATX-WTA's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, BDR has a market cap of 0. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while BDR trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas BDR's P/E ratio is -5.87. In terms of profitability, SONM's ROE is +6.68%, compared to BDR's ROE of +0.10%. Regarding short-term risk, SONM is more volatile compared to BDR. This indicates higher risk in terms of short-term price fluctuations for SONM.Check BDR's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, NMRX has a market cap of 0. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while NMRX trades at $3.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas NMRX's P/E ratio is N/A. In terms of profitability, SONM's ROE is +6.68%, compared to NMRX's ROE of -0.31%. Regarding short-term risk, SONM is more volatile compared to NMRX. This indicates higher risk in terms of short-term price fluctuations for SONM.Check NMRX's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, OCLR has a market cap of 0. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while OCLR trades at $8.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas OCLR's P/E ratio is 19.01. In terms of profitability, SONM's ROE is +6.68%, compared to OCLR's ROE of +0.11%. Regarding short-term risk, SONM is more volatile compared to OCLR. This indicates higher risk in terms of short-term price fluctuations for SONM.Check OCLR's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, EXFO has a market cap of 0. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while EXFO trades at $6.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas EXFO's P/E ratio is -56.31. In terms of profitability, SONM's ROE is +6.68%, compared to EXFO's ROE of -0.06%. Regarding short-term risk, SONM is more volatile compared to EXFO. This indicates higher risk in terms of short-term price fluctuations for SONM.Check EXFO's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, PLCM has a market cap of 0. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while PLCM trades at $12.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas PLCM's P/E ratio is 73.01. In terms of profitability, SONM's ROE is +6.68%, compared to PLCM's ROE of +0.07%. Regarding short-term risk, SONM is more volatile compared to PLCM. This indicates higher risk in terms of short-term price fluctuations for SONM.Check PLCM's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, GIMO has a market cap of 0. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while GIMO trades at $38.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas GIMO's P/E ratio is -1734.23. In terms of profitability, SONM's ROE is +6.68%, compared to GIMO's ROE of +0.24%. Regarding short-term risk, SONM is more volatile compared to GIMO. This indicates higher risk in terms of short-term price fluctuations for SONM.Check GIMO's competition here

DNA X, Inc. (NASDAQ: SONM) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SONM stands at 5.1M. In comparison, XXIA has a market cap of 0. Regarding current trading prices, SONM is priced at $3.39 on the NASDAQ, while XXIA trades at $19.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SONM currently has a P/E ratio of -0.12, whereas XXIA's P/E ratio is -54.24. In terms of profitability, SONM's ROE is +6.68%, compared to XXIA's ROE of -0.07%. Regarding short-term risk, SONM is more volatile compared to XXIA. This indicates higher risk in terms of short-term price fluctuations for SONM.Check XXIA's competition here